Prevention and Management of Meningococcal Disease in Adolescents

Links shared publicly online about this topic.

  • 456
    total visits

Prevention and Management of Meningococcal Disease in Adolescents

hcplive.com

Stephen I. Pelton, MD, talks about the clinical and epidemiological factors affecting the prevention and management of meningococcal disease in adolescents.

View full resource at hcplive.com

Tags: Disease and Condition, disease

  • Share

Most Recently Shared on March 7, 2011 at 8:37 pm By:

HCPLive_Peds HCPLive

Podcast: Prevention and Management of Meningococcal Disease in Adolescents http://hcp.lv/hhFDB9

1 year ago...

National Meningitis Association

nmaus.org — “A nonprofit organization founded by parents to educate parents, students, health professionals and public policy makers about the dangers of meningococcal disease and vaccination efforts.View full resource at nmaus.org

  • View Related
  • Share

Most Recently Shared on October 29, 2010 at 5:00 pm By:

shannonrosa Shannon Rosa Patient Advocate

Meningitis risks, prevention, stories - parents of adolescents, get informed! http://www.nmaus.org/programs/getting-it/

2 years ago...

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

news-medical.net — “Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 6:19 pm By:

Meningitis_News News-Medical.Net Health News

Meningitis News: Health Canada approves Novartis' Menveo for prevention of meningococcal disease: Novartis Pharmac... http://bit.ly/cktD6u

2 years ago...

Novartis meningococcal vaccine Menveo recommended for approval in the European Union for prevention of disease in adolescents and adults

novartis.com — “Novartis meningococcal vaccine Menveo recommended for approval in the European Union for prevention of disease in adolescents and adultsView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on December 21, 2009 at 2:36 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Novartis meningococcal vaccine Menveo® gets nod in EU for prevention of disease in adolescents and adults http://ow.ly/OeKd

2 years ago...

Advertisement